Brain Behav Immun 2001 Dec;15(4):388-400
Immunohistochemical Localization of Phosphorylated Glial Fibrillary Acidic
Protein in the Prefrontal Cortex and Hippocampus from Patients with
Schizophrenia, Bipolar Disorder, and Depression
Webster MJ, Knable MB, Johnston-Wilson N, Nagata K, Inagaki M, Yolken RH
Increasingly, abnormalities of glial cell function have been implicated in
pathological studies of the major mental illnesses (schizophrenia, bipolar
disorder, and major depression). In a recent proteomic study, four
isoforms of astrocytic glial fibrillary acidic protein (GFAP) were decreased in
one or more of these diseases. In the current study, we sought to
determine the immunohistochemical localization of phosphorylated GFAP (pGFAP) in
the prefrontal cortex and hippocampus and to describe possible disease-related
changes in the distribution of pGFAP containing astrocytes. In the
prefrontal cortex, interlaminar astrocytes in layer I and stellate astrocytes in
layers II and VI were labeled. Labeled cells were also present adjacent to
blood vessels in the gyral white matter and in underlying white matter
generally. In the hippocampus, labeled cells were present in the polymorphic
layer of the dentate gyrus. In the prefrontal cortex, schizophrenia and
major depression were characterized by decreased labeling of astrocytes adjacent
to blood vessels. There were no significant differences between the
diagnostic groups in the other prefrontal layers or in the hippocampus.
These results suggest that reduced numbers or functional regulation of pGFAP
containing astrocytes occurs in schizophrenia and major depression. The
mechanism by which this deficit occurs is not known, but it may adversely effect
the regulation of neuronal metabolism, communication, and response to injury.